Feedback-Amplified Drug Delivery of αPD-L1-Modified Lipoplatin for Chronological Synergy in NSCLC through PD-L1 Upregulation
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.5c12335 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Yi Cen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Fifth Affiliated Hospital, Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, NMPA and State Key Laboratory of Respirat…. Hauptthemen laut MEDLINE: Cisplatin, B7-H1 Antigen, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Medical Research Council, State Key Laboratory of Respiratory Disease.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fifth Affiliated Hospital, Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical Univ…
- Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, P. R. China.
- Institute of Biology and Medicine, College of Life Science and Health, Wuhan University of Science and Technology, Wuhan 430081, P. R. China.
- Department of Pulmonary and Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, P. R. China.
- State Key Laboratory of Respiratory Diseases, Guangdong Key Laboratory of Vascular Diseases, Guangzhou Institute of Respiratory Health, First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510120, P. R. Ch…
- Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119074.
ORCID-Profile: Wen-Xiu Qiu, You-Zhi Tang, Shi-Ying Li
Förderung
- National Key Research and Development Program of China
- National Medical Research Council
- State Key Laboratory of Respiratory Disease
- National Research Foundation Singapore
- Natural Science Foundation of Hubei Province
- Hubei Provincial Department of Education
- China Scholarship Council
- National Natural Science Foundation of China
Zitieren
APA
Cen, Y., Li, X. X., Chen, Y., Ou, X. C., Yu, B. X., Chen, X. Y., Liu, Y. B., Qiu, W. X., Chen, X., Tang, Y. Z., Wang, T., Ding, L. W., & Li, S. Y. (2025). Feedback-Amplified Drug Delivery of αPD-L1-Modified Lipoplatin for Chronological Synergy in NSCLC through PD-L1 Upregulation. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c12335
Vancouver
Cen Y, Li XX, Chen Y, Ou XC, Yu BX, Chen XY, et al. Feedback-Amplified Drug Delivery of αPD-L1-Modified Lipoplatin for Chronological Synergy in NSCLC through PD-L1 Upregulation. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c12335
BibTeX
@article{Cen2025,
author = {Cen, Yi and Li, Xin-Xuan and Chen, Ying and Ou, Xiao-Cheng and Yu, Bai-Xue and Chen, Xia-Yun and Liu, Yi-Bin and Qiu, Wen-Xiu and Chen, Xin and Tang, You-Zhi and Wang, Tao and Ding, Ling-Wen and Li, Shi-Ying},
title = {Feedback-Amplified Drug Delivery of αPD-L1-Modified Lipoplatin for Chronological Synergy in NSCLC through PD-L1 Upregulation},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.5c12335}
}
EUVIMED